These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17164822)

  • 61. Glial and neuroinflammatory targets for treating substance use disorders.
    Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
    Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nicotine addiction and the lure of reward.
    White FJ
    Nat Med; 1998 Jun; 4(6):659-60. PubMed ID: 9623965
    [No Abstract]   [Full Text] [Related]  

  • 63. Psychostimulants: Basic and Clinical Pharmacology.
    McCreary AC; Müller CP; Filip M
    Int Rev Neurobiol; 2015; 120():41-83. PubMed ID: 26070753
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuroimaging of the dopamine/reward system in adolescent drug use.
    Ernst M; Luciana M
    CNS Spectr; 2015 Aug; 20(4):427-41. PubMed ID: 26095977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phasic dopamine release in appetitive behaviors and drug addiction.
    Wanat MJ; Willuhn I; Clark JJ; Phillips PE
    Curr Drug Abuse Rev; 2009 May; 2(2):195-213. PubMed ID: 19630749
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kappa opioids as potential treatments for stimulant dependence.
    Prisinzano TE; Tidgewell K; Harding WW
    AAPS J; 2005 Oct; 7(3):E592-9. PubMed ID: 16353938
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protein kinases and addiction.
    Lee AM; Messing RO
    Ann N Y Acad Sci; 2008 Oct; 1141():22-57. PubMed ID: 18991950
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurophysiology and neurochemistry of drug dependence: a review.
    Kiyatkin EA
    Int J Neurosci; 1989 Feb; 44(3-4):283-316. PubMed ID: 2566587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Action of drugs of abuse on brain reward systems: an update with specific attention to opiates.
    Wise RA; Bozarth MA
    Pharmacol Biochem Behav; 1982 Aug; 17(2):239-43. PubMed ID: 6127721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Actions of drugs of abuse on brain reward systems: a reconsideration with specific attention to alcohol.
    Amit Z; Brown ZW
    Pharmacol Biochem Behav; 1982 Aug; 17(2):233-8. PubMed ID: 6127720
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.
    Bailey CP; Husbands SM
    Expert Opin Drug Discov; 2014 Nov; 9(11):1333-44. PubMed ID: 25253272
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia.
    Sarter M; Bruno JP; Parikh V; Martinez V; Kozak R; Richards JB
    EXS; 2006; 98():65-86. PubMed ID: 17019883
    [No Abstract]   [Full Text] [Related]  

  • 73. Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors.
    Vazey EM; den Hartog CR; Moorman DE
    Handb Exp Pharmacol; 2018; 248():239-260. PubMed ID: 29687164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Norepinephrine at the nexus of arousal, motivation and relapse.
    España RA; Schmeichel BE; Berridge CW
    Brain Res; 2016 Jun; 1641(Pt B):207-16. PubMed ID: 26773688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacogenetics of addiction therapy.
    Nielsen DA; Nielsen EM; Dasari T; Spellicy CJ
    Methods Mol Biol; 2014; 1175():589-624. PubMed ID: 25150877
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Functional neuroimaging of addiction].
    Takahashi H
    Nihon Rinsho; 2015 Sep; 73(9):1473-80. PubMed ID: 26394506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug addiction: a curable mental disorder?
    Liu JF; Li JX
    Acta Pharmacol Sin; 2018 Dec; 39(12):1823-1829. PubMed ID: 30382181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Protective Effect of Social Reward on Opioid and Psychostimulant Reward and Relapse: Behavior, Pharmacology, and Brain Regions.
    Venniro M; Marino RAM; Chow JJ; Caprioli D; Epstein DH; Ramsey LA; Shaham Y
    J Neurosci; 2022 Dec; 42(50):9298-9314. PubMed ID: 36517252
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuropharmacology of addiction and how it informs treatment.
    Lingford-Hughes A; Watson B; Kalk N; Reid A
    Br Med Bull; 2010; 96():93-110. PubMed ID: 21044987
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toll-Like Receptor 4: A Novel Target to Tackle Drug Addiction?
    Liu J; Li JX; Wu R
    Handb Exp Pharmacol; 2022; 276():275-290. PubMed ID: 35434747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.